share_log

TT BioPharm Has Received A Decision To Grant European Patent Number EP3283620 Titled "Modified Gamma Delta Cells And Uses Thereof (For The Treatment Of Cancer Or Infectious Diseases In A Human)"

TT BioPharm Has Received A Decision To Grant European Patent Number EP3283620 Titled "Modified Gamma Delta Cells And Uses Thereof (For The Treatment Of Cancer Or Infectious Diseases In A Human)"

TT BioPharm 已收到一项授予欧洲专利号 EP3283620 的决定,该专利号为 “改性伽玛三角洲细胞及其用途(用于治疗人类癌症或传染病)”
Benzinga ·  03/21 15:32

EP About this file - European Patent Register (epo.org)

EP 关于此文件-欧洲专利注册局 (epo.org)

Image
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发